Clin2
NCT07759258Possibly a fitNot yet recruiting

GLP-2 hormone and bowel inflammation after abdominal radiation

Radiation Enteritis

Part of Cancer, Digestive system clinical trials.

This study looks at how a hormone called GLP-2 (which helps protect the gut) changes during radiation therapy to the belly or pelvis, and whether it relates to side effects like radiation enteritis (inflammation of the gut). The goal is to better understand and possibly predict these side effects to improve care.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
18 years to 75 years
Study type
Observational

Who can take part

  • You are between 18 and 75 years old.
  • You have been diagnosed with cancer and are scheduled to receive radiation therapy to your belly (abdomen) or pelvis.
  • You do not currently have active inflammation of the intestines (enteritis) or moderate to severe diarrhea before starting radiation.
  • You are able to complete the radiation treatment and a follow-up visit about one month after treatment ends.
  • You are willing to provide blood samples and answer questionnaires about your symptoms, nutrition, and quality of life.
  • You are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07378631Recruiting
Chronic radiation bowel disease study

This study looks at how different types of chronic radiation enteropathy, a bowel condition caused by radiation therapy, are linked to patient outcomes. It may help doctors better predict how the condition progresses.

Guangzhou, Guangdong
NCT06617182Recruiting· Phase 2
Thalidomide and glutamine for radiation bowel injury

This trial tests whether combining thalidomide and glutamine helps people with bleeding caused by past radiation treatment to the abdomen or pelvis. The medication may reduce inflammation and help healing.

Xi'an, Shaanxi
NCT07528287Not yet recruiting
Studying blood markers for bowel damage from radiation

This study looks at how radiation therapy affects the intestines and may help find ways to predict and manage side effects. By participating, you could help doctors better understand and treat radiation-related gut problems.

NCT07231588Recruiting· Early Phase 1
Probiotic for stomach side effects during pelvic radiation

This trial tests an oral probiotic (a mix of 5 good bacteria) to see if it can reduce stomach and bowel side effects from pelvic radiation. It may help people undergoing radiation for certain pelvic cancers.

Cincinnati, Ohio
NCT06836960Enrolling by invitation· Phase 1/Phase 2
Gegen Qinlian Tang and Probiotics for radiation gut issues

This study tests if a traditional Chinese medicine formula (Gegen Qinlian Tang) plus probiotics can help people who have gut problems from radiation treatment for cancer. It may reduce diarrhea, pain, or other bowel symptoms caused by radiation.

Jiujiang, Jiangxi
NCT06410443Recruiting
Steroid treatment for radiation-induced bowel injury

This trial tests if local steroids can help heal bowel damage caused by radiation therapy for cancer. It may reduce pain, bleeding, and urgency, and improve quality of life.

Shenyang, Liaoning

Hear when a new Radiation Enteritis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.